ImmunityBio (IBRX) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Jun 2, 2026 |
| BTIG | Maintained | Buy | $12.00 | May 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | May 20, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | May 5, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Apr 21, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Apr 8, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Mar 26, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Mar 23, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Mar 17, 2026 |
| BTIG | Initiated Coverage | Buy | $13.00 | Mar 12, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Mar 9, 2026 |
| Piper Sandler | Maintained | Overweight | $12.00 from $7.00 | Mar 4, 2026 |
| D. Boral Capital | Maintained | Buy | $23.00 | Feb 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 from $10.00 | Feb 23, 2026 |
| D. Boral Capital | Maintained | Buy | $24.00 | Feb 19, 2026 |
| D. Boral Capital | Maintained | Buy | $24.00 | Feb 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $8.00 | Jan 26, 2026 |
| BTIG | Maintained | Buy | $9.00 from $6.00 | Jan 23, 2026 |
| D. Boral Capital | Maintained | Buy | $24.00 | Jan 23, 2026 |
| D. Boral Capital | Maintained | Buy | $24.00 | Jan 20, 2026 |
Frequently asked questions
Is IBRX a buy, sell, or hold?
Analysts covering ImmunityBio currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on IBRX?
On Jun 2, 2026, HC Wainwright & Co. maintained ImmunityBio at Buy with a price target of $15.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.